Jane Sparks, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 380 West 100 North, Suite A, Monticello, UT 84535 Phone: 435-587-5054 Fax: 435-587-3495 |
News Archive
Disputes between healthcare professionals and patients and/or their families about whether medical treatment is futile can be resolved through collaborative efforts and communication, say experts.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.
Dr. Christopher Travis, an intern in obstetrics-gynecology, has cared for patients with COVID-19 and performed surgery on women suspected of having the coronavirus. But the patient who arrived for a routine prenatal visit in two masks and gloves had a problem that wasn't physiological.
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
› Verified 6 days ago